Lead: Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis

Lead: Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis

How do people find hope in the darkest times? In this episode of 'This Week in Addiction Medicine,' you'll be taken on an analytical journey through the cost-effectiveness of contingency management for methamphetamine use disorder (MethUD). The episode breaks down a fascinating study that uses a microsimulation model to assess the financial and health impacts of 12-week and 24-week contingency management programs.

With incentives capped at $750 per patient, the study reveals intriguing insights into the quality-adjusted life years gained and the costs involved, providing a compelling case for these programs' economic viability. The episode doesn't stop there. It also touches on other key studies, including the concept of 'proportion of remission' for those battling polysubstance use disorder, offering a nuanced measure of recovery.

You'll also hear about the effectiveness of various treatment plans for opioid use disorder during pregnancy, shedding light on non-inferior results between different buprenorphine treatments. Zach Caruso guides listeners through these complex topics with clarity and ease, making this episode a must-listen for anyone interested in addiction medicine's latest findings. Whether you're a healthcare professional or someone personally affected by addiction, there's something valuable here for you. Are these innovative approaches the future of addiction treatment?

Tune in to find out!